Scott E Barbour/Getty Images
- The stunning success of Ozempic and Wegovy is having a big impact on Denmark's economy.
- Huge US sales have strengthened Denmark's currency while also lowering its interest rates.
- Denmark-based Novo Nordisk has seen its market value soar in the past year to the second largest European company.
Surging demand for effective weight-loss drugs in America is having a big impact on Denmark's economy in the form of lower interest rates and a strengthening currency.
Denmark-based Novo Nordisk manufactures Wegovy and Ozempic, a GLP-1 drug that helps patients lower their blood sugar levels and lose upwards of 25 pounds.